Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 | Choriogonadotrophin alpha injection | Hospital use only | |
 | Clomifene tablets | Specialist recommendation - ovulation induction | |
| Cyproterone acetate | ||
| Dutasteride capsules | RICaD | |
| Ethinylestradiol tablets | 2micrograms and 10micrograms who cannot tolerate or are allergic to first-line patches | |
| Finasteride 1mg tablets | Hyperandrogenism in women | |
 | Finasteride 5mg tablets | Men | |
| Nandrolone decanoate injection | Hospital use only | |
| Oxandrolone 2.5mg tablets | Burns use only | |
| Raloxifene tablets | ||
| Sustanon injection | ||
| Testosterone gel | Use in women with low libido approved by APC (unlicensed). Specialist to initiate and issue first supply. | |
| Testosterone implant | Hospital only - menopausal clinic | |
| Testosterone undecanoate injection (Nebido®) | ||
| Tibolone 2.5mg tablets |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
